InterContinental Hotels Group PLC (IHG)
NYSE: IHG · Real-Time Price · USD
123.77
+7.30 (6.27%)
At close: Aug 7, 2025, 4:00 PM
121.08
-2.69 (-2.17%)
Pre-market: Aug 8, 2025, 4:46 AM EDT
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Theseus Pharmaceuticals.
Price Target: $0.00 (0.00%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell Initiates n/a | Strong Sell | Initiates | n/a | n/a | Feb 24, 2025 |
| Barclays | Barclays | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Nov 15, 2024 |
| Bernstein | Bernstein | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Mar 13, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 13, 2024 |
| Societe Generale | Societe Generale | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 7, 2024 |
Financial Forecast
Revenue This Year
2.54B
from 4.92B
Decreased by -48.34%
Revenue Next Year
2.70B
from 2.54B
Increased by 6.10%
EPS This Year
5.06
from 3.85
Increased by 31.39%
EPS Next Year
5.73
from 5.06
Increased by 13.15%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.6B | 2.8B | 3.0B | |
| Avg | 2.5B | 2.7B | 2.9B | |
| Low | 2.4B | 2.5B | 2.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -46.4% | 9.7% | 11.3% | |
| Avg | -48.3% | 6.1% | 5.9% | |
| Low | -51.4% | -1.1% | -2.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.54 | 6.67 | 7.75 | ||
| Avg | 5.06 | 5.73 | 6.45 | ||
| Low | 4.25 | 4.48 | 4.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.9% | 31.7% | 35.3% | ||
| Avg | 31.4% | 13.1% | 12.6% | ||
| Low | 10.2% | -11.5% | -12.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.